Our new @JAMANetworkOpen study suggests that the public sector played a leading role in the development of therapeutics and vaccines to combat #COVID-19. @LSHTM_GHECO@LSEHealthPolicy
Full paper: https://t.co/wrC9iq8UK3
What were the major sources of funding for clinical trials focused on the development of #therapeutics and #vaccines against #COVID-19 between Jan 20 - Aug 21? 🤔
Find out now📜with @Aris_Angelis@csualon@ekyriopoulos new paper ❗
here: https://t.co/lW4Y6QkgC6
The #AMR pandemic is not a future problem. #GRAMpaper in today's @TheLancet shows huge scale of the burden with people in #LMICs bearing the brunt
https://t.co/jvRNnVspS1
Better access and appropriate usage are critical in #pharma's response
#AMRSOS#StopSuperbugs @UKAMREnvoy
Many medicines for children still come as hard pills or bitter syrups that are difficult to swallow. Of the 1,073 R&D projects assessed by #ATMI21, only 69 target children under the age of 12. Read the new analysis: https://t.co/1RbOFCKDxK #access2meds
🆕New @AtMIndex finding online now: Children are last in line for meds. But #pharma can turn the tide, with the arrival of a number of game-changing new meds. 🌍💊
Read our latest research on how to ramp up access: https://t.co/1RbOFCKDxK
OFF WE GO!
Today we launch a European Citizens' Initiative. We need 1 million signatures to make @EuropeanCommiss make anti-pandemic vaccines and treatments a global public good, accessible to everyone.
#NoProfitOnPandemic#Right2Cure
👉https://t.co/4KeNcIlXUs 👈
Our EURO leadership team is joining us from @LSHTM. Thank you to Laura and the rest of the team for the introduction! We can't wait to see the amazing work you do #IWGInceptionMeeting
Staggering progress in 🇪🇸 Covid response guided by Health Minister @salvadorilla ✅ 1% positivity rate ✅ 60%/ new patients through contact tracing ✅ testing capacity ⏫. 👏👏👏Vigilance towards mini outbreaks in the new reality. Full support by @WHO_Europe